Zobrazeno 1 - 10
of 75
pro vyhledávání: '"JA Perini"'
Publikováno v:
Occupational Toxicology.
Introduction Benzene is identified as a carcinogen. Long-term exposure to benzene causes haematological alterations, including an increased risk of acute myeloid leukaemia. However, the molecular mechanisms of Benzene systems effects remain poorly un
Autor:
Perini JA; Departamento de Farmácia, Laboratório de Pesquisa de Ciências Farmacêuticas (LAPESF), Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil., Basta PC; Departamento de Endemias Samuel Pessoa, Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz (ENSP/Fiocruz), Rio de Janeiro, Brazil., Cardoso JV; Departamento de Farmácia, Laboratório de Pesquisa de Ciências Farmacêuticas (LAPESF), Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil., Elias ABR; Departamento de Pesquisa, Divisão de Pesquisa Clínica e Desenvolvimento Tecnológico, Coordenação de Pesquisa, Instituto Nacional de Câncer, Rio de Janeiro, Brazil., Suarez-Kurtz G; Departamento de Pesquisa, Divisão de Pesquisa Clínica e Desenvolvimento Tecnológico, Coordenação de Pesquisa, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
Publikováno v:
Pharmacogenetics and genomics [Pharmacogenet Genomics] 2024 Dec 01; Vol. 34 (9), pp. 269-274. Date of Electronic Publication: 2024 Sep 10.
Autor:
Perini JA; Research Laboratory of Pharmaceutical Sciences (LAPESF), Rio de Janeiro State University (West Zone-UERJ-ZO), Rio de Janeiro 23070-200, RJ, Brazil.; Post-Graduation Program in Environmental Science and Technology, Rio de Janeiro State University (West Zone-UERJ-ZO), Rio de Janeiro 23070-200, RJ, Brazil., Silva YMHD; Research Laboratory of Pharmaceutical Sciences (LAPESF), Rio de Janeiro State University (West Zone-UERJ-ZO), Rio de Janeiro 23070-200, RJ, Brazil.; Post-Graduation Program in Environmental Science and Technology, Rio de Janeiro State University (West Zone-UERJ-ZO), Rio de Janeiro 23070-200, RJ, Brazil., Silva MCD; Research Laboratory of Pharmaceutical Sciences (LAPESF), Rio de Janeiro State University (West Zone-UERJ-ZO), Rio de Janeiro 23070-200, RJ, Brazil., Silva BP; Research Laboratory of Pharmaceutical Sciences (LAPESF), Rio de Janeiro State University (West Zone-UERJ-ZO), Rio de Janeiro 23070-200, RJ, Brazil., Machado DE; Research Laboratory of Pharmaceutical Sciences (LAPESF), Rio de Janeiro State University (West Zone-UERJ-ZO), Rio de Janeiro 23070-200, RJ, Brazil., Moreira MFR; Center for Studies on Worker Health and Human Ecology (CESTEH), National School of Public Health (ENSP), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro 21041-210, RJ, Brazil.
Publikováno v:
Toxics [Toxics] 2024 Aug 31; Vol. 12 (9). Date of Electronic Publication: 2024 Aug 31.
Autor:
Silva MCD; Research Laboratory of Pharmaceutical Sciences (LAPESF), State University of Rio de Janeiro (West Zone-UERJ-ZO), Rio de Janeiro 23070-200, RJ, Brazil.; Program of Post-Graduation in Public Health and Environment, National School of Public Health (ENSP), Oswald Cruz Foundation (Fiocruz), Rio de Janeiro 21040-900, RJ, Brazil., Basta PC; Program of Post-Graduation in Public Health and Environment, National School of Public Health (ENSP), Oswald Cruz Foundation (Fiocruz), Rio de Janeiro 21040-900, RJ, Brazil.; Department of Endemic Diseases Samuel Pessoa, National School of Public Health (ENSP), Oswald Cruz Foundation (Fiocruz), Rio de Janeiro 21041-210, RJ, Brazil., Hofer CB; Department of Infectious Diseases, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-630, RJ, Brazil., Oliveira MAF; Psychology Division, Central Institute of the Hospital das Clínicas, School of Medicine, University of São Paulo (DIP/ICHC-FMUSP), São Paulo 05403-000, SP, Brazil., Kempton JW; Faculty of Medicine, St Mary's Hospital, Imperial College London, London W2 1PG, UK., Oliveira RAA; Faculty of Medicine, University of São Paulo (USP), São Paulo 01246-903, SP, Brazil., Vasconcellos ACS; Laboratory of Professional Education in Health Surveillance, Polytechnic School of Health Joaquim Venâcio (EPSJV), Oswald Cruz Foundation (Fiocruz), Rio de Janeiro 21040-900, RJ, Brazil., Perini JA; Research Laboratory of Pharmaceutical Sciences (LAPESF), State University of Rio de Janeiro (West Zone-UERJ-ZO), Rio de Janeiro 23070-200, RJ, Brazil.
Publikováno v:
Toxics [Toxics] 2024 Jun 19; Vol. 12 (6). Date of Electronic Publication: 2024 Jun 19.
Autor:
Perini JA; Research Laboratory of Pharmaceutical Sciences (LAPESF), State University of Rio de Janeiro (UERJ), Rio de Janeiro 23070-200, Brazil.; Laboratório de Educação Profissional em Vigilância em Saúde, Escola Politécnica de Saúde Joaquim Venâncio, Fundação Oswaldo Cruz (EPSJV/Fiocruz), Av. Brasil, 4365-Manguinhos, Rio de Janeiro 21040-900, Brazil., Cardoso JV; Research Laboratory of Pharmaceutical Sciences (LAPESF), State University of Rio de Janeiro (UERJ), Rio de Janeiro 23070-200, Brazil., Knesse AO; Research Laboratory of Pharmaceutical Sciences (LAPESF), State University of Rio de Janeiro (UERJ), Rio de Janeiro 23070-200, Brazil., Pessoa-Silva FO; Research Laboratory of Pharmaceutical Sciences (LAPESF), State University of Rio de Janeiro (UERJ), Rio de Janeiro 23070-200, Brazil., Vasconcellos ACS; Laboratório de Educação Profissional em Vigilância em Saúde, Escola Politécnica de Saúde Joaquim Venâncio, Fundação Oswaldo Cruz (EPSJV/Fiocruz), Av. Brasil, 4365-Manguinhos, Rio de Janeiro 21040-900, Brazil., Machado DE; Research Laboratory of Pharmaceutical Sciences (LAPESF), State University of Rio de Janeiro (UERJ), Rio de Janeiro 23070-200, Brazil., Basta PC; Program of Post-Graduation in Public Health and Environment, National School of Public Health (ENSP), Oswald Cruz Foundation (Fiocruz), Rio de Janeiro 21041-210, Brazil.; Department of Endemic Diseases Samuel Pessoa, ENSP, Fiocruz, Rio de Janeiro 21041-210, Brazil.
Publikováno v:
Toxics [Toxics] 2024 Mar 20; Vol. 12 (3). Date of Electronic Publication: 2024 Mar 20.
Autor:
Marques IS; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/Pathology and Laboratory Medicine Dep. Clinical Pathology SV/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072 Porto, Portugal.; Faculty of Sciences of University of Porto (FCUP), 4169-007 Porto, Portugal., Tavares V; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/Pathology and Laboratory Medicine Dep. Clinical Pathology SV/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072 Porto, Portugal.; Faculty of Medicine of University of Porto (FMUP), 4200-072 Porto, Portugal.; ICBAS-Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4099-002 Porto, Portugal., Vieira Neto B; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/Pathology and Laboratory Medicine Dep. Clinical Pathology SV/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072 Porto, Portugal.; Research Department, Portuguese League Against Cancer (NRNorte), 4200-172 Porto, Portugal., Lopes LR; Pharmaceutical Sciences Research Laboratory (LAPESF), State University of Rio de Janeiro (UERJ), Rio de Janeiro 23070-200, Brazil.; Programa de Pós-Graduação em Saúde Pública e Meio Ambiente, Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil., Goes RA; Research Division, Instituto Nacional de Traumatologia e Ortopedia (INTO), Rio de Janeiro 20940-070, Brazil.; University Clinic of Orthopedics and Traumatology, Faculty of Medicine of Lisbon, 1649-028 Lisbon, Portugal., Guimarães JAM; Research Division, Instituto Nacional de Traumatologia e Ortopedia (INTO), Rio de Janeiro 20940-070, Brazil., Perini JA; Pharmaceutical Sciences Research Laboratory (LAPESF), State University of Rio de Janeiro (UERJ), Rio de Janeiro 23070-200, Brazil., Medeiros R; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/Pathology and Laboratory Medicine Dep. Clinical Pathology SV/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072 Porto, Portugal.; Faculty of Medicine of University of Porto (FMUP), 4200-072 Porto, Portugal.; ICBAS-Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4099-002 Porto, Portugal.; Research Department, Portuguese League Against Cancer (NRNorte), 4200-172 Porto, Portugal.; Faculty of Health Sciences, Fernando Pessoa University, 4200-150 Porto, Portugal.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 14; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 14.
Autor:
Pijeira MSO; Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmaceuticals and Synthesis of Novel Radiopharmaceuticals, Rio de Janeiro 21941906, Brazil., Gomes-da-Silva NC; Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmaceuticals and Synthesis of Novel Radiopharmaceuticals, Rio de Janeiro 21941906, Brazil., Ricci-Junior E; School of Pharmacy, DEFARMED, Rio de Janeiro Federal University, Rio de Janeiro 21941900, Brazil., Alencar LMR; Department of Physics, Laboratory of Biophysics and Nanosystems, Federal University of Maranhão, Maranhão 65080-805, Brazil., İlem-Özdemir D; School of Pharmacy, Department of Radiopharmacy, Ege University, 35040 Bornova, Izmir, Turkey., Cavalcanti ADS; Research Division, National Institute of Traumatology and Orthopedics, Rio de Janeiro 20940-070, Brazil; State University of Rio de Janeiro, Research Laboratory of Pharmaceutical Sciences, Rio de Janeiro 23070200, Brazil., Machado DE; State University of Rio de Janeiro, Research Laboratory of Pharmaceutical Sciences, Rio de Janeiro 23070200, Brazil., Perini JA; State University of Rio de Janeiro, Research Laboratory of Pharmaceutical Sciences, Rio de Janeiro 23070200, Brazil., Santos-Oliveira R; Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmaceuticals and Synthesis of Novel Radiopharmaceuticals, Rio de Janeiro 21941906, Brazil; State University of Rio de Janeiro, Laboratory of Radiopharmacy and Nanoradiopharmaceuticals, Rio de Janeiro 23070200, Brazil. Electronic address: roliveira@ien.gov.br.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2024 Mar 05; Vol. 652, pp. 123765. Date of Electronic Publication: 2024 Jan 07.
Autor:
Perini JA; Laboratório de Pesquisa de Ciências Farmacêuticas (LAPESF), Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil., Basta PC; Departamento de Endemias Samuel Pessoa, Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz (ENSP/Fiocruz), Rio de Janeiro, Brazil., Suarez-Kurtz G; Divisão de Pesquisa Clínica e Desenvolvimento Tecnológico, Coordenação de Pesquisa, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2024 Feb 06; Vol. 15, pp. 1359570. Date of Electronic Publication: 2024 Feb 06 (Print Publication: 2024).
Autor:
Araujo Junior AEP; Spine Surgery Center, National Institute of Traumatology and Orthopedics (INTO), Rio de Janeiro, RJ, Brazil.; Department of Orthopedics and Traumatology Surgery, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., de Azevedo GBL; Spine Surgery Center, National Institute of Traumatology and Orthopedics (INTO), Rio de Janeiro, RJ, Brazil.; Department of Orthopedics and Traumatology Surgery, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Moliterno LAM; Spine Surgery Center, National Institute of Traumatology and Orthopedics (INTO), Rio de Janeiro, RJ, Brazil.; Department of Orthopedics and Traumatology Surgery, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Tavares RH; Spine Surgery Center, National Institute of Traumatology and Orthopedics (INTO), Rio de Janeiro, RJ, Brazil., Cardoso JV; Pharmaceutical Sciences Research Laboratory (LAPESF), State University of Rio de Janeiro (UERJ), Av. Manuel Caldeira de Alvarenga, 1.203, Rio de Janeiro, 23070-200, Brazil., de Souza GR; Pharmaceutical Sciences Research Laboratory (LAPESF), State University of Rio de Janeiro (UERJ), Av. Manuel Caldeira de Alvarenga, 1.203, Rio de Janeiro, 23070-200, Brazil.; Research Division, INTO, Rio de Janeiro, RJ, Brazil., Guimarães JAM; Research Division, INTO, Rio de Janeiro, RJ, Brazil., Defino HLA; Department of Orthopedics and Traumatology Surgery, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil., Perini JA; Pharmaceutical Sciences Research Laboratory (LAPESF), State University of Rio de Janeiro (UERJ), Av. Manuel Caldeira de Alvarenga, 1.203, Rio de Janeiro, 23070-200, Brazil. jamilaperini@yahoo.com.br.
Publikováno v:
European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society [Eur Spine J] 2024 Feb; Vol. 33 (2), pp. 646-654. Date of Electronic Publication: 2023 Oct 06.
Autor:
Cardoso JV; Laboratório de Pesquisa de Ciências Farmacêuticas (LAPESF), Universidade do Estado do Rio de Janeiro (UERJ), RJ, Brazil., Machado DE; Laboratório de Pesquisa de Ciências Farmacêuticas (LAPESF), Universidade do Estado do Rio de Janeiro (UERJ), RJ, Brazil., da Silva MC; Laboratório de Pesquisa de Ciências Farmacêuticas (LAPESF), Universidade do Estado do Rio de Janeiro (UERJ), RJ, Brazil., de Mello MP; Laboratório de Pesquisa de Ciências Farmacêuticas (LAPESF), Universidade do Estado do Rio de Janeiro (UERJ), RJ, Brazil., Berardo PT; Serviço de Ginecologia, Hospital Federal dos Servidores do Estado (HFSE), Rio de Janeiro, Brazil., Medeiros R; Grupo de Oncologia Molecular e Patologia Viral, Centro de Investigação do Instituto Português de Oncologia do Porto (IPO Porto)/Dep. Patologia e Medicina Laboratorial, Patologia Clínica SV/ (Rede de Investigação em Saúde)/Porto, Centro Abrangente de Oncologia, Porto, Portugal., Perini JA; Laboratório de Pesquisa de Ciências Farmacêuticas (LAPESF), Universidade do Estado do Rio de Janeiro (UERJ), RJ, Brazil. Electronic address: jamilaperini@yahoo.com.br.
Publikováno v:
Human immunology [Hum Immunol] 2023 Oct; Vol. 84 (10), pp. 561-566. Date of Electronic Publication: 2023 Jul 18.